These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18922938)

  • 21. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CpG island methylator phenotype in breast cancer is associated with the lobular subtype.
    Roessler J; Ammerpohl O; Gutwein J; Steinemann D; Schlegelberger B; Weyer V; Sariyar M; Geffers R; Arnold N; Schmutzler R; Bartram CR; Heinrich T; Abbas M; Antonopoulos W; Schipper E; Hasemeier B; Kreipe H; Lehmann U
    Epigenomics; 2015; 7(2):187-99. PubMed ID: 25347269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue.
    Kwon MS; Kim SJ; Lee SY; Jeong JH; Lee ES; Kang HS
    Oncol Rep; 2006 Jan; 15(1):27-32. PubMed ID: 16328031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol.
    Medina-Aguilar R; Pérez-Plasencia C; Marchat LA; Gariglio P; García Mena J; Rodríguez Cuevas S; Ruíz-García E; Astudillo-de la Vega H; Hernández Juárez J; Flores-Pérez A; López-Camarillo C
    PLoS One; 2016; 11(6):e0157866. PubMed ID: 27355345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
    El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
    Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative methylation of intron motifs is associated with cancer-related gene expression in both canine mammary tumor and human breast cancer.
    Nam AR; Lee KH; Hwang HJ; Schabort JJ; An JH; Won SH; Cho JY
    Clin Epigenetics; 2020 Jul; 12(1):110. PubMed ID: 32693820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic inactivation of the HOXA gene cluster in breast cancer.
    Novak P; Jensen T; Oshiro MM; Wozniak RJ; Nouzova M; Watts GS; Klimecki WT; Kim C; Futscher BW
    Cancer Res; 2006 Nov; 66(22):10664-70. PubMed ID: 17090521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
    Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
    Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma.
    Rumbajan JM; Maeda T; Souzaki R; Mitsui K; Higashimoto K; Nakabayashi K; Yatsuki H; Nishioka K; Harada R; Aoki S; Kohashi K; Oda Y; Hata K; Saji T; Taguchi T; Tajiri T; Soejima H; Joh K
    BMC Cancer; 2013 Dec; 13():608. PubMed ID: 24373183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.
    Rauch TA; Zhong X; Wu X; Wang M; Kernstine KH; Wang Z; Riggs AD; Pfeifer GP
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):252-7. PubMed ID: 18162535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
    Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
    Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
    Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression.
    Yagi S; Hirabayashi K; Sato S; Li W; Takahashi Y; Hirakawa T; Wu G; Hattori N; Hattori N; Ohgane J; Tanaka S; Liu XS; Shiota K
    Genome Res; 2008 Dec; 18(12):1969-78. PubMed ID: 18971312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas.
    Shiraishi M; Sekiguchi A; Oates AJ; Terry MJ; Miyamoto Y
    Oncogene; 2002 May; 21(22):3659-62. PubMed ID: 12032868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
    Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
    Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.
    Ballestar E; Paz MF; Valle L; Wei S; Fraga MF; Espada J; Cigudosa JC; Huang TH; Esteller M
    EMBO J; 2003 Dec; 22(23):6335-45. PubMed ID: 14633992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.